Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.
InfuSystem Holdings, Inc. provides health care services that facilitate outpatient care for durable medical equipment manufacturers and health care providers. News for INFU commonly covers financial results, segment trends and operating updates across Patient Services and Device Solutions, including oncology, pain management, wound therapy, direct payer rentals, pump and consumable sales, and biomedical services and repair.
Company updates also address revenue cycle management, payer-network and billing efficiency initiatives, relationships with DME manufacturers, contract economics, margin performance, cash flow, guidance and management presentations at investor conferences.
InfuSystem Holdings reported first quarter 2020 net revenues of $21.6 million, an increase of 18% year-over-year, driven by growth in both segments. Gross profit rose 22% to $12.7 million, with a gross margin of 58.8%. The company achieved an adjusted EBITDA of $4.1 million, marking a 30% increase. The net loss improved to $(0.4 million) or $(0.02) per diluted share. Despite challenges from COVID-19, oncology billings reached record levels. However, pain management revenues declined due to elective surgery delays, impacting overall performance.